Friday, July 15, 2022
9:41 AM EST – Intellipharmaceutics International Inc. : Announced today that its financial statements for the interim period ended May 31, 2022 and related management’s discussion and analysis and accompanying Chief Executive Officer and Chief Financial Officer certificates due July 15, will not be filed by the Filing Deadline.
Intellipharmaceutics International Inc. (T.IPCI ) shares were unchanged at 0.12.
Stocks in Play: Intellipharmaceutics International Inc., Fri, 15 Jul 2022 09:42:08 EST